|
PNMA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1228999999835E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27409999994832E-06 |
| Normal-vs-Stage2 |
1.011710E-04 |
| Normal-vs-Stage3 |
3.059800E-01 |
| Normal-vs-Stage4 |
2.684200E-01 |
| Stage1-vs-Stage2 |
6.878800E-01 |
| Stage1-vs-Stage3 |
7.830400E-02 |
| Stage1-vs-Stage4 |
7.055200E-01 |
| Stage2-vs-Stage3 |
1.080240E-01 |
| Stage2-vs-Stage4 |
6.550200E-01 |
| Stage3-vs-Stage4 |
5.893600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1452999999495E-06 |
| Normal-vs-AfricanAmerican |
3.247200E-04 |
| Normal-vs-Asian |
7.497600E-01 |
| Caucasian-vs-AfricanAmerican |
8.221800E-01 |
| Caucasian-vs-Asian |
6.448000E-01 |
| AfricanAmerican-vs-Asian |
6.766000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94899999472753E-08 |
| Normal-vs-Female |
1.686790E-01 |
| Male-vs-Female |
3.624100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.394700E-04 |
| Normal-vs-Extreme_Weight |
6.82919999994702E-07 |
| Normal-vs-Obese |
5.756300E-03 |
| Normal-vs-Extreme_Obese |
1.264970E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.923800E-01 |
| Normal_Weight-vs-Obese |
3.899000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.700400E-01 |
| Extreme_Weight-vs-Obese |
1.587950E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.972800E-01 |
| Obese-vs-Extreme_Obese |
8.328200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.918400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.049300E-04 |
| Normal-vs-Age(61-80Yrs) |
6.30019999503517E-08 |
| Normal-vs-Age(81-100Yrs) |
1.54259999995965E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.911600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.234300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.050270E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.753800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.048200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.981200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.34380000027923E-07 |
| Normal-VS-Type2 PRCC |
3.83459999999669E-05 |
| Normal-VS-KIRP CIMP |
1.245970E-01 |
| Normal-VS-Unclassified PRCC |
2.950900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.654800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.736030E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.606200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.747970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.415800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.712330E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.44389999962225E-07 |
| Normal-vs-N1 |
8.988200E-01 |
| Normal-vs-N2 |
9.437500E-04 |
| N0-vs-N1 |
1.540230E-02 |
| N0-vs-N2 |
4.994400E-01 |
| N1-vs-N2 |
1.581990E-01 |
|
|
